Wedbush Securities Inc Genocea Biosciences, Inc. Transaction History

Wedbush Securities Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$1.81 - $5.53 $82,382 - $251,697	-45,515 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$1.66 - $3.06 $75,554 - $139,275	45,515 New	45,515 $105,000
Q1 2020 Apr 17, 2020	SELL	$1.26 - $2.73 $24,066 - $52,143	-19,100 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$2.05 - $2.82 $39,155 - $53,862	19,100 New	19,100 $40,000
Q3 2019 Oct 17, 2019	SELL	$2.9 - $4.07 $31,900 - $44,770	-11,000 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$3.47 - $6.71 $38,170 - $73,810	11,000 New	11,000 $43,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.